SG11201700276QA - Quinoxaline compounds, method for preparing the same and use thereof - Google Patents
Quinoxaline compounds, method for preparing the same and use thereofInfo
- Publication number
- SG11201700276QA SG11201700276QA SG11201700276QA SG11201700276QA SG11201700276QA SG 11201700276Q A SG11201700276Q A SG 11201700276QA SG 11201700276Q A SG11201700276Q A SG 11201700276QA SG 11201700276Q A SG11201700276Q A SG 11201700276QA SG 11201700276Q A SG11201700276Q A SG 11201700276QA
- Authority
- SG
- Singapore
- Prior art keywords
- preparing
- same
- quinoxaline compounds
- quinoxaline
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462025212P | 2014-07-16 | 2014-07-16 | |
| PCT/US2015/035822 WO2016010662A1 (en) | 2014-07-16 | 2015-06-15 | Quinoxaline compounds, method for preparing the same and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700276QA true SG11201700276QA (en) | 2017-02-27 |
Family
ID=55078907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700276QA SG11201700276QA (en) | 2014-07-16 | 2015-06-15 | Quinoxaline compounds, method for preparing the same and use thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10745360B2 (ja) |
| EP (1) | EP3169670B1 (ja) |
| JP (1) | JP6826526B6 (ja) |
| KR (1) | KR102433758B1 (ja) |
| CN (2) | CN106536488A (ja) |
| AU (1) | AU2015290176B2 (ja) |
| CA (1) | CA2954879C (ja) |
| MX (1) | MX2017000544A (ja) |
| NZ (1) | NZ728498A (ja) |
| SG (1) | SG11201700276QA (ja) |
| TW (1) | TWI565698B (ja) |
| WO (1) | WO2016010662A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7394768B2 (ja) * | 2017-09-20 | 2023-12-08 | エイビーエム セラピューティックス コーポレイション | キナーゼ阻害剤としての環状イミノピリミジン誘導体 |
| CN114605391B (zh) * | 2022-02-21 | 2024-01-26 | 广州六顺生物科技股份有限公司 | 喹喔啉类衍生物及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060010568A1 (en) * | 2004-01-27 | 2006-01-19 | Wiles William A | Helmet sweat band |
| WO2006040568A1 (en) * | 2004-10-15 | 2006-04-20 | Astrazeneca Ab | Quinoxalines as b raf inhibitors |
| EP2170830B1 (en) * | 2007-07-17 | 2014-10-15 | Plexxikon, Inc. | 2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS |
| KR101819257B1 (ko) * | 2010-07-13 | 2018-01-16 | 다카라 텔레시스템즈 가부시키가이샤 | X선 단층상 촬영 장치 |
| WO2012118492A1 (en) * | 2011-03-01 | 2012-09-07 | Array Biopharma Inc. | Heterocyclic sulfonamides as raf inhibitors |
| WO2013032951A1 (en) * | 2011-08-26 | 2013-03-07 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| WO2013043935A1 (en) * | 2011-09-21 | 2013-03-28 | Neupharma, Inc. | Certain chemical entites, compositions, and methods |
-
2015
- 2015-06-15 KR KR1020177002931A patent/KR102433758B1/ko active IP Right Grant
- 2015-06-15 CN CN201580038477.1A patent/CN106536488A/zh active Pending
- 2015-06-15 MX MX2017000544A patent/MX2017000544A/es unknown
- 2015-06-15 NZ NZ728498A patent/NZ728498A/en unknown
- 2015-06-15 AU AU2015290176A patent/AU2015290176B2/en active Active
- 2015-06-15 CN CN202310977136.7A patent/CN117088821A/zh active Pending
- 2015-06-15 JP JP2017502707A patent/JP6826526B6/ja active Active
- 2015-06-15 WO PCT/US2015/035822 patent/WO2016010662A1/en active Application Filing
- 2015-06-15 SG SG11201700276QA patent/SG11201700276QA/en unknown
- 2015-06-15 US US15/326,490 patent/US10745360B2/en active Active
- 2015-06-15 EP EP15822821.3A patent/EP3169670B1/en active Active
- 2015-06-15 CA CA2954879A patent/CA2954879C/en active Active
- 2015-06-16 TW TW104119488A patent/TWI565698B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017521449A (ja) | 2017-08-03 |
| CA2954879C (en) | 2022-09-06 |
| EP3169670A4 (en) | 2017-05-24 |
| US10745360B2 (en) | 2020-08-18 |
| WO2016010662A9 (en) | 2016-08-25 |
| TW201609673A (zh) | 2016-03-16 |
| EP3169670B1 (en) | 2021-10-20 |
| TWI565698B (zh) | 2017-01-11 |
| CA2954879A1 (en) | 2016-01-21 |
| WO2016010662A1 (en) | 2016-01-21 |
| AU2015290176A1 (en) | 2017-02-16 |
| JP6826526B6 (ja) | 2021-03-31 |
| MX2017000544A (es) | 2017-03-08 |
| KR20170030550A (ko) | 2017-03-17 |
| CN106536488A (zh) | 2017-03-22 |
| NZ728498A (en) | 2022-07-01 |
| US20180208561A1 (en) | 2018-07-26 |
| CN117088821A (zh) | 2023-11-21 |
| KR102433758B1 (ko) | 2022-08-19 |
| AU2015290176B2 (en) | 2019-10-31 |
| JP6826526B2 (ja) | 2021-02-03 |
| EP3169670A1 (en) | 2017-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232140A1 (zh) | 微類器官以及製造和使用它們的方法 | |
| IL252053A0 (en) | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders | |
| SG11201703235YA (en) | Activated carbon, hydrochar and processes for making same | |
| SG11201608711RA (en) | Material itq-55, method for preparation and use | |
| IL287645A (en) | Cytotoxic and anti-mitotic compounds and methods for their use | |
| EP3115361A4 (en) | Heterocyclic compounds, and preparation method and use thereof | |
| SG11201608943VA (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
| SG11201702215RA (en) | Polishing composition, method for manufacturing same, and polishing method | |
| GB2509431B (en) | Herbicidal composition, a method for its preparation and the use thereof | |
| HUE052730T2 (hu) | Eljárás klór elõállításához használt katalizátor elõállítására, katalizátor és eljárás klór elõállítására | |
| IL257337A (en) | A silica-based biomolecule carrier, a pharmaceutical preparation containing it, a method of preparation and its use | |
| SG11201703631VA (en) | Novel carbodiimides, method for the production and use thereof | |
| GB201810964D0 (en) | Decoquinate solid dispersion, method for preparing same and use thereof | |
| EP3177744A4 (en) | Material, method&component | |
| EP3112351A4 (en) | Naphthylamide compound, preparation method and use thereof | |
| EP3157016A4 (en) | Scintillator, preparing method thereof, and application thereof | |
| PL3157901T3 (pl) | Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki | |
| HK1254379A1 (zh) | 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途 | |
| PL3178803T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
| PL3240828T3 (pl) | Kompozycja poliolefinowa i sposób jej wytwarzania | |
| RO130539B8 (ro) | Compoziţie erbicidă, procedeu de preparare şi utilizarea acesteia | |
| ZA202004349B (en) | Fluoralkenyl compounds, process for preparation and use thereof | |
| SG11201701887XA (en) | Methods for preparing and collecting polyaromatic compounds, and products comprising polyaromatic compounds | |
| SG11201700276QA (en) | Quinoxaline compounds, method for preparing the same and use thereof | |
| PL3234494T3 (pl) | Maszyna do wyrzucania rzutków i sposób jej regulowania |